Fang Xueling, Xu Mi, Fang Qiang, Tan Haiqin, Zhou Jiale, Li Ziqin, Li Fan, Yang Shangxin
Department of Intensive Care Unit, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
IngeniGen XunMinKang Biotechnology Inc., Hangzhou, China.
Open Forum Infect Dis. 2018 May 16;5(6):ofy114. doi: 10.1093/ofid/ofy114. eCollection 2018 Jun.
Metagenomic sequencing has shown tremendous promise in solving difficult infectious diseases cases. In this study, we utilized this technology to help guide the care of a critically ill patient with severe pneumonia, fever of unknown origin, and subsequent encephalitis in the intensive care unit (ICU).
Shotgun metagenomic sequencing was performed on the patient's blood, bronchoalveolar lavage (BAL), and cerebral spinal fluid by using an Illumina MiniSeq sequencer.
A high load of human adenovirus B55 (HAdV-B55), a highly pathogenic adenovirus associated with numerous recently reported outbreaks and deaths in China, was detected in both blood and BAL, which explained the severity of the condition. The patient was treated with intravenous ribavirin, which cleared the virus after 26 days. Metagenomic sequencing also helped diagnose an unexpected herpes simplex virus-1 encephalitis during hospitalization, which led to timely treatment.
This was the first successful case utilizing metagenomic sequencing to guide diagnosis and treatment in the ICU setting in China. We have proven the concept that metagenomic sequencing can play an important role in determining clinical approaches and ultimately in improving patient outcomes. We also hope to share our successful treatment protocol for the severe pneumonia and viremia caused by HAdV-B55.
宏基因组测序在解决疑难感染性疾病病例方面显示出巨大潜力。在本研究中,我们利用该技术帮助指导一名重症监护病房(ICU)中患有重症肺炎、不明原因发热及随后出现脑炎的危重症患者的治疗。
使用Illumina MiniSeq测序仪对患者的血液、支气管肺泡灌洗(BAL)液和脑脊液进行鸟枪法宏基因组测序。
在血液和BAL液中均检测到高载量的人腺病毒B55(HAdV-B55),这是一种高致病性腺病毒,与中国近期报道的众多疫情和死亡事件相关,这解释了病情的严重程度。患者接受了静脉注射利巴韦林治疗,26天后病毒清除。宏基因组测序还帮助在住院期间诊断出意外的单纯疱疹病毒1型脑炎,从而得以及时治疗。
这是中国首例在ICU环境中利用宏基因组测序指导诊断和治疗的成功病例。我们证明了宏基因组测序在确定临床治疗方法以及最终改善患者预后方面可发挥重要作用这一概念。我们还希望分享我们针对HAdV-B55引起的重症肺炎和病毒血症的成功治疗方案。